Investment firms Asabys Partners, VI Partners and CDTI Innvierte led the $17m Series E round in Medlumics. Other participants are existing investors Andera Partners, Caixa Capital Risc and Innogest. “We have been following Medlumics for years. We were immediately excited by the last developments of the company and are thrilled to collaborate with a very experienced team at the maturation of a technology that could impact the life of hundreds of thousands of patients worldwide," Josep Ll. Sanfeliu, Asabys Managing Partner.